BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 18954412)

  • 1. Psychosocial outcome following genetic risk counselling for familial colorectal cancer. A comparison of affected patients and family members.
    Keller M; Jost R; Haunstetter CM; Sattel H; Schroeter C; Bertsch U; Cremer F; Kienle P; Tariverdian M; Kloor M; Gebert J; Brechtel A
    Clin Genet; 2008 Nov; 74(5):414-24. PubMed ID: 18954412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer.
    Gritz ER; Peterson SK; Vernon SW; Marani SK; Baile WF; Watts BG; Amos CI; Frazier ML; Lynch PM
    J Clin Oncol; 2005 Mar; 23(9):1902-10. PubMed ID: 15774782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.
    van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
    Patient Educ Couns; 2007 Jan; 65(1):58-68. PubMed ID: 16872788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Family communication, genetic testing and colonoscopy screening in hereditary non-polyposis colon cancer: a qualitative study.
    McCann S; MacAuley D; Barnett Y; Bunting B; Bradley A; Jeffers L; Morrison PJ
    Psychooncology; 2009 Nov; 18(11):1208-15. PubMed ID: 19177338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer.
    Watson M; Lloyd S; Davidson J; Meyer L; Eeles R; Ebbs S; Murday V
    Br J Cancer; 1999 Feb; 79(5-6):868-74. PubMed ID: 10070883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motivations and psychosocial impact of genetic testing for HNPCC.
    Esplen MJ; Madlensky L; Butler K; McKinnon W; Bapat B; Wong J; Aronson M; Gallinger S
    Am J Med Genet; 2001 Sep; 103(1):9-15. PubMed ID: 11562928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How families communicate about HNPCC genetic testing: findings from a qualitative study.
    Peterson SK; Watts BG; Koehly LM; Vernon SW; Baile WF; Kohlmann WK; Gritz ER
    Am J Med Genet C Semin Med Genet; 2003 May; 119C(1):78-86. PubMed ID: 12704641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study.
    van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; van Gool AR; Klijn JG; Tibben A
    Clin Genet; 2007 Jan; 71(1):35-42. PubMed ID: 17204044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary nonpolyposis colorectal carcinoma (HNPCC) and HNPCC-like families: Problems in diagnosis, surveillance, and management.
    Lynch HT; Riley BD; Weissman SM; Coronel SM; Kinarsky Y; Lynch JF; Shaw TG; Rubinstein WS
    Cancer; 2004 Jan; 100(1):53-64. PubMed ID: 14692024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colon cancer screening practices following genetic testing for hereditary nonpolyposis colon cancer (HNPCC) mutations.
    Halbert CH; Lynch H; Lynch J; Main D; Kucharski S; Rustgi AK; Lerman C
    Arch Intern Med; 2004 Sep; 164(17):1881-7. PubMed ID: 15451763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer risk in young women at risk of hereditary nonpolyposis colorectal cancer: implications for gynecologic surveillance.
    Brown GJ; St John DJ; Macrae FA; Aittomäki K
    Gynecol Oncol; 2001 Mar; 80(3):346-9. PubMed ID: 11263929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient accuracy of reporting on hereditary non-polyposis colorectal cancer-related malignancy in family members.
    Katballe N; Juul S; Christensen M; Ørntoft TF; Wikman FP; Laurberg S
    Br J Surg; 2001 Sep; 88(9):1228-33. PubMed ID: 11531872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Familial colorectal cancer].
    Sunde LE; Bülow S; Bernstein IT
    Ugeskr Laeger; 2006 Jun; 168(24):2369-73. PubMed ID: 16822423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors for hereditary cancer distress six months after BRCA1/2 or HNPCC genetic susceptibility testing.
    van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
    Eur J Cancer; 2007 Jan; 43(1):71-7. PubMed ID: 17045473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumour distribution. A report of 121 families with proven mutations.
    Barrow E; Alduaij W; Robinson L; Shenton A; Clancy T; Lalloo F; Hill J; Evans DG
    Clin Genet; 2008 Sep; 74(3):233-42. PubMed ID: 18554281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychologic distress after disclosure of genetic test results regarding hereditary nonpolyposis colorectal carcinoma.
    Murakami Y; Okamura H; Sugano K; Yoshida T; Kazuma K; Akechi T; Uchitomi Y
    Cancer; 2004 Jul; 101(2):395-403. PubMed ID: 15241839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct contact in inviting high-risk members of hereditary colon cancer families to genetic counselling and DNA testing.
    Aktan-Collan K; Haukkala A; Pylvänäinen K; Järvinen HJ; Aaltonen LA; Peltomäki P; Rantanen E; Kääriäinen H; Mecklin JP
    J Med Genet; 2007 Nov; 44(11):732-8. PubMed ID: 17630403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive genetic counseling for families at risk for HNPCC: impact on distress and perceptions.
    Keller M; Jost R; Haunstetter CM; Kienle P; Knaebel HP; Gebert J; Sutter C; Knebel-Doeberitz Mv; Cremer F; Mazitschek U
    Genet Test; 2002; 6(4):291-302. PubMed ID: 12537653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hereditary nonpolyposis colorectal cancer (Lynch syndrome): a review of the literature and case reports].
    Lucci S; Pasta V; Arcieri S; Rivolta R; Candioli S; Manigrasso A; Papetti MT; Cerutti L; Merlino G
    G Chir; 2000 Apr; 21(4):177-87. PubMed ID: 10812774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attitudes toward colon cancer gene testing: factors predicting test uptake.
    Codori AM; Petersen GM; Miglioretti DL; Larkin EK; Bushey MT; Young C; Brensinger JD; Johnson K; Bacon JA; Booker SV
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):345-51. PubMed ID: 10207639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.